Clinical Trial: Heart and Vascular

Interrupt AF

Full Name

Prospective Evaluation of Open Irrigated Ablation Catheters With High Resolution Mapping to Treat Paroxysmal Atrial Fibrillation

Description

Purpose: To assess outcomes for the Rhythmia Mapping System in conjunction with Boston Scientific Open-Irrigated Ablation Catheters to treat de novo Paroxysmal Atrial Fibrillation. De Novo PAF is defined as subjects undergoing first ablation procedure for PAF with no prior left atrial ablation

All subjects fitting the enrollment criteria, signing the consent and undergoing the procedure with the study devices will be followed up for 3 years to collect data.

Eligibility

Inclusion Criteria

Inclusion criteria includes, but may not be limited to, the following:

20 years or older
history of recurrent symptomatic Paroxysmal Atrial Fibrillation
eligible for an ablation procedure

To participate:

Please contact Kristen Cornell, RN, Network Office of Research and Innovation at 610-402-9543.

Doctor(s) Running This Study

Hari P. Joshi, MD

Specialties

Cardiology
Electrophysiology

Area of focus i

Atrial Fibrillation
Cardiac Arrhythmias
Pacemaker and Defibrillators

Affiliated with

Make an Appointment

LVPG Cliniciani

Accepting New Patients

Locations (2)Phone

LVPG Cardiology-Muhlenberg

2649 Schoenersville Road
Suite 301
Bethlehem, PA 18017-7332
United States

LVPG Cardiology-Muhlenberg

2649 Schoenersville Road
Suite 301
Bethlehem, PA 18017-7332
United States

LVPG Cardiology-Easton

2401 Northampton Street
Suite 200
Easton, PA 18045-2764
United States

LVPG Cardiology-Easton

2401 Northampton Street
Suite 200
Easton, PA 18045-2764
United States